Follow the 藥華藥 share price and the full insider trade history of the company, a listed issuer based in Taiwan. Shares are listed on the TW market, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €568.9bn. The latest transaction was disclosed on 31 July 2026 (Gift). Among the most active insiders: 詹青柳. The full history is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 藥華藥 Buy (bullish), based on 8 analysts. Average price target: NT$1,312.
Fundamental score
Ranked 6,439 of 29,063 companies
65.6
score / 100
Value
40
Quality
91
FCF yld0.6%
Earn yld0.9%
EV/EBITDA·
ROE23%
Gross mgn89%
Net mgn32%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.